NL8503341A - Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten. - Google Patents

Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten. Download PDF

Info

Publication number
NL8503341A
NL8503341A NL8503341A NL8503341A NL8503341A NL 8503341 A NL8503341 A NL 8503341A NL 8503341 A NL8503341 A NL 8503341A NL 8503341 A NL8503341 A NL 8503341A NL 8503341 A NL8503341 A NL 8503341A
Authority
NL
Netherlands
Prior art keywords
sterol biosynthesis
pharmaceutical preparations
active substance
biosynthesis inhibitors
preparation
Prior art date
Application number
NL8503341A
Other languages
English (en)
Dutch (nl)
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Priority to NL8503341A priority Critical patent/NL8503341A/nl
Priority to EP86202127A priority patent/EP0228113A2/fr
Publication of NL8503341A publication Critical patent/NL8503341A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NL8503341A 1985-12-03 1985-12-03 Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten. NL8503341A (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL8503341A NL8503341A (nl) 1985-12-03 1985-12-03 Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten.
EP86202127A EP0228113A2 (fr) 1985-12-03 1986-12-01 Utilisation des inhibiteurs de la biosynthèse des stérols pour combattre certaines bactéries gram-négatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8503341A NL8503341A (nl) 1985-12-03 1985-12-03 Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten.
NL8503341 1985-12-03

Publications (1)

Publication Number Publication Date
NL8503341A true NL8503341A (nl) 1987-07-01

Family

ID=19846960

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8503341A NL8503341A (nl) 1985-12-03 1985-12-03 Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten.

Country Status (2)

Country Link
EP (1) EP0228113A2 (fr)
NL (1) NL8503341A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055129A1 (fr) * 1999-03-18 2000-09-21 Sumitomo Pharmaceuticals Co., Ltd. Derives de dithiocarbonimidate
CN105028419B (zh) * 2012-08-17 2017-06-16 陕西美邦农药有限公司 一种含氯苯嘧啶醇的杀菌组合物
NL2020073B1 (en) 2017-12-12 2019-06-19 Itrec Bv Marine j-lay pipelaying system and method

Also Published As

Publication number Publication date
EP0228113A2 (fr) 1987-07-08

Similar Documents

Publication Publication Date Title
Lampert Toxicity of the blue-green Microcystis aeruginosa: Effective defence mechanism against grazing pressure by Daphnia: With 3 figures and 2 tables in the text
Anderson et al. An in-vitro evaluation of the cellular uptake and infraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent
Keen et al. Hydroxyphaseollin and related isoflavanoids in the hypersensitive resistance reaction of soybeans to Pseudomonas glycinea
Felix D'Mello et al. Pesticide use and mycotoxin production in Fusarium and Aspergillus phytopathogens
Kendall et al. Changes in sensitivity to DMI fungicides in Rhynchosporium secalis
Nikitina et al. Antibacterial activity of polyphenolic compounds isolated from plants of Geraniaceae and Rosaceae families
Kiviranta et al. Toxicity of cyanobacteria to mosquito larvae—screening of active compounds
Vesonder et al. Phytotoxic activity of selected water-soluble metabolites of Fusarium against Lemna minor L.(Duckweed)
Dekker et al. Acquired resistance to pimaricin in Cladosporium cucumerinum and Fusarium oxysporum f. sp. narcissi associated with decreased virulence
Gomi et al. Wolbachia having no effect on reproductive incompatibility in Tetranychus kanzawai Kishida (Acari: Tetranychidae)
Budhathoki et al. Screening of actinomycetes from soil for antibacterial activity
Buchenauer Mechanism of action of the fungicide imazalil in Ustilago avenae/Wirkungsmechanismus des Fungizids Imazalil in Ustilago avenae
Bushmann et al. Antibacterial compounds in estuarine submersed aquatic plants
NL8503341A (nl) Toepassing van sterolbiosynthese-remmers als actieve stof bij het bereiden van farmaceutische preparaten voor het bestrijden van (pathogene) micro-organismen van een bepaald type, alsmede de verkregen farmaceutische preparaten.
Chelkowski et al. Fusarium sporotrichioides Sherb., Fusarium tricinctum (Corda) Sacc. and Fusarium poae (Peck) Wollenw.—Cultural Characteristics, Toxinogenicity and Pathogenicity Towards Cereals
Barna et al. The influence of nitrogen nutrition on the sensitivity of tomato plants to culture filtrates of Fusarium and to fusaric acid
Mace et al. Relation between sensitivity to terpenoid phytoalexins and virulence to cotton of Verticillium dahliae strains
CN113287620A (zh) 1H-吡唑并[3,4-d]嘧啶类化合物在制备禾谷镰刀菌杀菌剂中的应用
Okuno et al. Mode of action of ferimzone, a novel systemic fungicide for rice diseases: Biological properties against Pyricularia oryzae in vitro.
Yates Bioassay systems and their use in the diagnosis of mycotoxicoses
Hollomon A laboratory assay to determine the sensitivity of Rhynchosporium secalis to the fungicide triadimenol
D’Mello et al. 3-Acetyl deoxynivalenol production in a strain of Fusarium culmorum insensitive to the fungicide difenoconazole
Belakhov et al. Imbricin, an antifungal antibiotic of non-medical application: Preparation, physicochemical properties, structural features, and industrial and agricultural uses
Polacheck et al. The susceptibility of Cryptococcus neoformans to an antimycotic agent (G2) from alfalfa
Biles et al. Differential chlorate inhibition of Chaetomium globosum germination, hyphal growth, and perithecia synthesis

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed